PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $233,014 | -65.0% | 5,627 | -59.0% | 0.00% | -100.0% |
| Q1 2023 | $665,033 | +193.9% | 13,729 | +131.6% | 0.00% | – |
| Q4 2022 | $226,310 | -5.3% | 5,929 | +24.5% | 0.00% | – |
| Q3 2022 | $239,000 | -1.2% | 4,761 | -32.6% | 0.00% | -100.0% |
| Q4 2018 | $242,000 | -37.0% | 7,060 | -74.2% | 0.00% | -50.0% |
| Q3 2016 | $384,000 | -60.4% | 27,400 | -80.2% | 0.00% | -60.0% |
| Q2 2016 | $970,000 | +9.0% | 138,200 | 0.0% | 0.01% | -37.5% |
| Q1 2016 | $890,000 | -72.9% | 138,200 | +36.4% | 0.01% | -60.0% |
| Q4 2015 | $3,282,000 | +27.7% | 101,300 | +5.2% | 0.02% | +25.0% |
| Q3 2015 | $2,571,000 | -38.9% | 96,300 | +10.2% | 0.02% | -30.4% |
| Q2 2015 | $4,207,000 | +25.0% | 87,400 | +58.0% | 0.02% | +27.8% |
| Q1 2015 | $3,365,000 | +106.3% | 55,300 | +75.6% | 0.02% | +125.0% |
| Q4 2014 | $1,631,000 | – | 31,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |